DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 17,629 Value ($000) $256 Avg Close $14.37 Range $12.58 - $16.20

Q2 2025

Shares 50,809 Value ($000) $711 Avg Close $14.07 Range $10.57 - $16.97

Q1 2025

Shares 13,729 Value ($000) $187 Avg Close $19.16 Range $13.30 - $24.34

Q4 2024

Shares 22,601 Value ($000) $461 Avg Close $25.60 Range $19.93 - $33.33

Q2 2023

Shares 8,898 Value ($000) $263 Avg Close $28.12 Range $22.72 - $33.31

Q1 2023

Shares 11,782 Value ($000) $271 Avg Close $27.52 Range $21.74 - $32.81

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	17,629	$256	$14.37	$12.58 - $16.20
Q2 2025	50,809	$711	$14.07	$10.57 - $16.97
Q1 2025	13,729	$187	$19.16	$13.30 - $24.34
Q4 2024	22,601	$461	$25.60	$19.93 - $33.33
Q2 2023	8,898	$263	$28.12	$22.72 - $33.31
Q1 2023	11,782	$271	$27.52	$21.74 - $32.81